Synergistic effect of methotrexate and infliximab on activated lymphocyte apoptosis.
van den Brande
Jan M H
JM
Peppelenbosch
Maikel P
MP
Hommes
Daan W
DW
D000893:Anti-Inflammatory Agents / Q000494:pharmacology; D000911:Antibodies, Monoclonal / Q000494:pharmacology*; D017209:Apoptosis / Q000187:drug effects*; D004357:Drug Synergism; D006801:Humans; D007166:Immunosuppressive Agents / Q000494:pharmacology; D000069285:Infliximab; D008213:Lymphocyte Activation; D008727:Methotrexate / Q000494:pharmacology*; D014409:Tumor Necrosis Factor-alpha / Q000276:immunology
D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D007166:Immunosuppressive Agents; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab; D008727:Methotrexate